Skip to main content


Biotech stock mailbag: mid-year assessment, where we go from here

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

'Mad Money' Lightning Round: Be Careful With Fitbit

Cramer says Dow Chemical is undervalued and Nokia is never coming back.

Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks

When investors get complacent, they miss out on great opportunities to buy, Cramer says.

Stocks climb slightly in may despite fed fears

U.S. markets ended May on a positive note, despite fears over the likelihood of a summer rate hike by the Federal Reserve that made trading unpredictable.

Stocks on track for mixed May as Dow loses gains

Stock are on track for a mixed month as escalating fears over the likelihood of a summer rate hike from the Federal Reserve erases gains for the Dow.

Breaking News

Twitter Stock Leaps As Elon Musk Adds More Equity To $44 Billion Takeover Bid, Closes Tesla Margin Loan

Elon Musk has closed out his margin loans, linked to Tesla shares, and pledged another $6.25 billion in equity to fund his $44 billion takeover of the social media website.

Nvidia Stock: Investors Are Buying the Dip. Where From Here?

Nvidia stock is being bought on the dip. Here's how traders should approach it now.

Macy's Stock Soars On Q1 Earning Beat, 2022 Profit Forecast Boost As Shoppers Defy Inflation Gloom

"While macroeconomic pressures on consumer spending increased during the quarter, our customers continued to shop," said CEO Jeff Gennette.

Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.